Silencing of this gene dramatically reduced resistance of CRC cells to fluorouracil and oxaliplatin [71] and lowered the level of anti-apoptotic BCL2 protein in CRC and other types of cancer [72]. This evidence concerns the gene BCL2 and cancer.